Compartir
Recent Progress in the Treatment of Acute Lymphoblastic Leukemia, an Issue of Hematology/Oncology Clinics of North America: Volume 23-5 (en Inglés)
Wendy Stock
(Autor)
·
Meir Wetzler
(Autor)
·
Saunders
· Tapa Dura
Recent Progress in the Treatment of Acute Lymphoblastic Leukemia, an Issue of Hematology/Oncology Clinics of North America: Volume 23-5 (en Inglés) - Stock, Wendy ; Wetzler, Meir
$ 273.751
$ 456.252
Ahorras: $ 182.501
Elige la lista en la que quieres agregar tu producto o crea una nueva lista
✓ Producto agregado correctamente a la lista de deseos.
Ir a Mis Listas
Origen: Reino Unido
(Costos de importación incluídos en el precio)
Se enviará desde nuestra bodega entre el
Martes 20 de Agosto y el
Jueves 29 de Agosto.
Lo recibirás en cualquier lugar de Colombia entre 1 y 5 días hábiles luego del envío.
Reseña del libro "Recent Progress in the Treatment of Acute Lymphoblastic Leukemia, an Issue of Hematology/Oncology Clinics of North America: Volume 23-5 (en Inglés)"
Acute lymphoblastic leukemia (ALL) is the most common malignancy diagnosed in children, representing nearly one third of all pediatric cancers. The annual incidence of ALL is about 30 cases per million people, with a peak incidence in children aged 2-5 years. Although a few cases are associated with inherited genetic syndromes, the cause of ALL remains largely unknown. This issue presents articles that discuss current thinking on the diagnosis and treatment of the disease. Articles specifically emphasize molecular genetics, allogeneic stem cell transplantation, and treatments including, clofarabine, nelarabine, rituximab, and PegAsp.